A head-to-head comparison of breast lesion’s conspicuity at contrast-enhanced mammography and contrast-enhanced MRI
Question Lesion conspicuity is a new descriptor for lesion enhancement according to the new CEM lexicon. Data correlating lesion conspicuity with malignancy likelihood are limited. Findings Lesion conspicuity is higher for contrast-enhanced-MRI than for contrast-enhanced mammography (CEM) for all lesions but significantly better for benign lesions. Clinical relevance The low conspicuity of benign lesions on CEM may reduce false-positive results, making it a valuable tool in breast cancer screening.
Authors
- Thomas H. Helbich (ORCID: https://orcid.org/0000-0003-3169-778X)
- Ambra Santonocito (ORCID: https://orcid.org/0000-0001-6271-1383)
- Pascal Baltzer (ORCID: https://orcid.org/0000-0002-3755-5398)
- Calogero Zarcaro (ORCID: https://orcid.org/0000-0001-9910-2469)
- Panagiotis Kapetas (ORCID: https://orcid.org/0000-0003-2505-4753)
- Paola Clauser (ORCID: https://orcid.org/0000-0002-2365-6905)
- Layla Zeitouni (ORCID: https://orcid.org/0000-0001-9714-936X)
- Francesca Ferrara (ORCID: https://orcid.org/0000-0003-2677-3362)
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Memorial Sloan Kettering Cancer Center (US)
- King Faisal Specialist Hospital & Research Centre (SA)
- Vienna General Hospital (AT)
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Radiology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1007/s00330-024-11195-4
- Citations
- 10
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 4.04
Funders
- Vienna Science and Technology Fund
- Bracco Imaging